Medical Health & Life Science Research News

Report explores the overactive bladder treatment market forecast to 2022

Medical Market Research

Overactive bladder treatment market is projected to reach USD 4.19 Billion by 2022 from USD 3.63 Billion in 2017, at a CAGR of 2.9%.

- Advertising -

Study on Overactive Bladder Treatment Market highlights key players such as Astellas Pharma, Inc. (Japan), Pfizer, Inc. (U.S.), Teva Pharmaceutical Industries Limited (Israel), Allergan, Plc (Ireland), Medtronic plc (Ireland), Mylan N.V. (U.S.), Endo International plc (Ireland), Hisamitsu Pharmaceutical Co.,Inc. (Japan), Sanofi (France), Aurobindo Pharma Limited (India), Apotex, Inc.

- Advertising -

(Canada), and Cogentix Medical, Inc. (U.S.).

The growth of this market is majorly driven by the increasing geriatric population and consequently rising prevalence of bladder overactivity, aggressive marketing strategies by pharma companies, and the development of new therapies to treat bladder overactivity. However, the undesired systemic effects caused by anticholinergics may hinder the growth of the market to a certain extent.

Get sample copy of this research @…ple?rname=1151258

The U.S.held the largest share of the global overactive bladder treatment market in 2016, while the Rest of Asia-Pacific (RoAPAC) is expected to witness the highest growth during 2017 to 2022. Growing healthcare expenditure in countries like India, China, and Singapore; favorable demographics; and aggressive marketing by pharma companies leading to rising awareness on OAB are the key factors responsible for the growth of this market in the Ro APAC region.

Key Points From Table Of Content:

5 Global Overactive Bladder Treatment Market, By Pharmacotherapy
5.1 Introduction
5.2 Anticholinergics
5.2.1 Solifenacin
5.2.2 Oxybutynin
5.2.3 Fesoterodine
5.2.4 Darifenacin
5.2.5 Tolterodine
5.2.6 Trospium
5.2.7 Other Anticholinergics
5.3 Mirabegron
5.4 Botox
5.5 Neurostimulation
5.6 Intravesical Instillation

Get This Report @…unt?rname=1151258

6 Global Overactive Bladder Treatment Market, By Disease
6.1 Introduction
6.2 Idiopathic Overactive Bladder
6.3 Neurogenic Overactive Bladder
6.3.1 Introduction
6.3.2 Overactive Bladder in Parkinson's Disease
6.3.3 Overactive Bladder in Stroke
6.3.4 Overactive Bladder in Multiple Sclerosis
6.3.5 Overactive Bladder in Spinal Cord Injury
6.3.6 Overactive Bladder in Other Disorders

The report analyzes the overactive bladder treatment market and aims at estimating the market size and future growth potential of this market based on various segments such as pharmacotherapy, disease type, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

News From

RnR Market Research - Market Research and Competitive Analysis ReportsRnR Market Research
Category: Market Research Publishers and RetailersCompany about: is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
This email address is being protected from spambots. You need JavaScript enabled to view it.